Clin2
NCT07534709Possibly a fitNot yet recruiting

A new non-opioid painkiller for recovery after C-section

Cesarean DeliveryCesarean SectionPain, PostoperativeOpioid Consumption, Postoperative

Treatments studied

Part of Pain clinical trials.

This study tests a new non-opioid pain medicine called suzetrigine to help women recover from C-section without relying on opioids. If you're having a C-section and want to manage pain during recovery with a non-opioid option, this trial may be a good fit.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
90 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be a woman aged 18 or older
  • You must be having a C-section (cesarean delivery) during this hospital stay
  • Your C-section must be done with spinal or epidural anesthesia (not general anesthesia)
  • The cut for your C-section must be a horizontal bikini-line incision (Pfannenstiel)
  • You must be able to answer follow-up questions by phone or online for up to 14 days after delivery
  • You must agree not to breastfeed or provide breast milk to your baby while taking the study drug plus 96 hours after the last dose

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California
NCT07796152Not yet recruiting· Phase 4
Comparing pain relief options after knee replacement

This study compares two pain relief approaches after knee replacement surgery to see which works better. If you qualify, you will receive either the study medication or standard care to manage your pain.

Skokie, Illinois
NCT07654296Not yet recruiting· Phase 3
Suzetrigine for pain relief after ureteroscopy

This trial tests a new non-opioid pain medication called suzetrigine to see if it can help reduce pain after ureteroscopy, a procedure often used to treat kidney stones. If you're having this procedure, the study may help you manage pain with fewer side effects than opioids.

Boston, Massachusetts
NCT07864896Recruiting· Phase 3
Study of a new pain medicine after knee replacement surgery

This trial tests a new oral pain medicine called suzetrigine for people who have a knee replacement. It aims to see if it helps control pain after surgery better or with fewer side effects than usual care.

New York, New York
NCT07856654Not yet recruiting· Phase 4
Pain relief after pelvic surgery

This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.

Austin, Texas
NCT07836010Not yet recruiting· Phase 4
Added pain medicine for women having minimally invasive hysterectomy

This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.

Hear when a new Cesarean Delivery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.